Predictors of Vision Loss After Lapse in Antivascular Endothelial Growth Factor Treatment in Patients With Diabetic Macular Edema

On this episode of the JVRD Author’s Forum podcast, Dr. Katherine E. Talcott of the Cole Eye Institute at the Cleveland Clinic discusses ‘Predictors of Vision Loss After Lapse in Antivascular Endothelial Growth Factor Treatment in Patients With Diabetic Macular Edema,’ published in the March/April 2025 issue of JVRD.Host Dr. Timothy Murray and Dr. Talcott discuss the clinical implications of treatment lapses in patients with diabetic macular edema and the importance of identifying individuals at higher risk for vision loss. Dr. Talcott highlights key predictors of vision loss, such as longer lapses, diabetic foot disease, and Medicaid insurance, and discusses how these insights can guide personalized care, improve patient counseling, and support proactive interventions to preserve vision in this vulnerable population.For more information, visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.

There are no comments yet.

Please log in to write the first comment.